Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study - Ikuta, Katsuya; Hanashi, Hideki; Hirai, Kozo; Ota, Yoshiaki; Matsuyama, Yutaka; Shimura, Asami; Terauchi, Masaru; Momoeda, Mikio (International journal of hematology, 2019)
Keywords: Adult; Anemia; Anemia, Iron-Deficiency - drug therapy; Anemia, Iron-Deficiency - etiology; Female; Ferric Compounds - administration & dosage; Ferric Compounds - adverse effects; Ferric oxide; Ferric Oxide, Saccharated - administration & dosage; Ferric Oxide, Saccharated - adverse effects; Hematite; Hematology; Hemoglobin; Hemoglobins - analysis; Humans; Intravenous administration; Iron; Iron deficiency; Japan; Maltose - administration & dosage; Maltose - adverse effects; Maltose - analogs & derivatives; Medicine; Medicine & Public Health; Menorrhagia - complications; Middle Aged; Nutrient deficiency; Oncology; Original Article; Patients; Randomization; Safety; Treatment Outcome; Young Adult; Japan; Iron-deficiency anemia (IDA); Hypermenorrhea; Intravenous iron; Ferric carboxymaltose (FCM); Japan